Down-regulation of STAT3 expression using vector-based RNA interference promotes apoptosis in Hepatocarcinoma cells
Source abstract
Abstract
In this study, we followed a DNA vector-based RNAi approach to silence the signal transducer and activator of transcription 3 (STAT3) expression in Bel-7402 cells, to explore how the Janus kinase (JAK)/STAT3 signaling pathway influences the apoptosis of hepatocarcinoma cells. According to GenBank's STAT3 cDNA, the plasmid pGCsi.U6/neoRFP STAT3, which was designed for expression of STAT3 small interfering RNA (siRNA), was constructed and synthesized, and then transfected into Bel-7402 cells using Lipofectamine 2000. Cells with or without siRNA transfection were treated in wells. The apoptotic rate was detected by flow cytometry (FCM) and by staining with the Annexin V/propidium iodide (PI) apoptosis detection kit. Simultaneously, the mitochondrial membrane potential (ΔΨm) was visualized by JC-1 fluorescence staining and observed using the inverted fluorescence microscope. Furthermore, the expression of caspase-3 protein was analyzed by Western blotting. The results showed that treatment with STAT3 siRNA displayed effects in the Bel-7402 cells, causing a significantly increased apoptotic ratio (P < 0.05). The mitochondrial membrane potential of the STAT3 siRNA group, observed by the JC-1 fluorescence staining, decreased significantly. The protein expression of active caspase-3 increased with STAT3 siRNA treatment, and was significantly higher than that of the control group (P < 0.05). STAT3 gene-silencing significantly improves the apoptotic effect against Bel-7402 cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cytokine Signaling Pathways and Interactions · interferon and immune responses · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Oncology, Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
Department of Oncology, The Central Hospital of Panjin, Panjin, P.R. China
Department of thoracic surgery, Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, P.R. China
Department of General Surgery, The Central Hospital of Panjin, Panjin, P.R. China
References (25)
Show source-provided references
1. 10.1096/fj.04-2664fje10.1096/fj.04-2664fje ↗
2. 10.1371/journal.pcbi.003022510.1371/journal.pcbi.0030225 ↗
3. 10.1016/j.ccr.2009.01.00910.1016/j.ccr.2009.01.009 ↗
4. 10.1016/j.bbrc.2005.07.07510.1016/j.bbrc.2005.07.075 ↗
5. Chiablaem K · Anticancer Res · 2014 · 34 · 1857
6. 10.1038/gt.2013.3510.1038/gt.2013.35 ↗
7. 10.1016/j.bbrc.2010.02.15210.1016/j.bbrc.2010.02.152 ↗
8. 10.1158/1078-0432.CCR-05-014810.1158/1078-0432.CCR-05-0148 ↗
9. 10.1016/j.canlet.2014.04.00610.1016/j.canlet.2014.04.006 ↗
10. 10.1186/1476-4598-13-710.1186/1476-4598-13-7 ↗
11. Li K · Cancer Res · 2003 · 63 · 3593
12. 10.1158/1078-0432.CCR-06-048410.1158/1078-0432.CCR-06-0484 ↗
13. 10.1007/s00535-005-1566-310.1007/s00535-005-1566-3 ↗
14. 10.1007/s00204-006-0066-410.1007/s00204-006-0066-4 ↗
15. 10.1038/sj.onc.120585910.1038/sj.onc.1205859 ↗
16. 10.1158/0008-5472.CAN-08-254510.1158/0008-5472.CAN-08-2545 ↗
17. 10.1089/omi.2012.004810.1089/omi.2012.0048 ↗
18. 10.2174/138161205454669910.2174/1381612054546699 ↗
19. 10.1186/1476-4598-13-6610.1186/1476-4598-13-66 ↗
20. 10.1016/j.ccr.2013.08.02310.1016/j.ccr.2013.08.023 ↗
21. 10.1111/bph.1230210.1111/bph.12302 ↗
22. 10.1126/science.125145610.1126/science.1251456 ↗
23. 10.1093/jn/136.3.60810.1093/jn/136.3.608 ↗
24. 10.2741/s5110.2741/s51 ↗
25. 10.1053/j.gastro.2008.05.02510.1053/j.gastro.2008.05.025 ↗